Venue: First floor, 65 Gresham Street, London EC2V 7NQ
On November 21, the British Biosimilars Association (BBA) will be staging its second annual conference looking at the latest clinical best practice in the use and uptake of biosimilars within the NHS. The key note speakers will be Peter Huskinson, Commercial Director and Suzy Heafield, Commercial Pharmacy Medicines Optimisation Lead at NHS England. Further discussion panels will take place throughout the day aimed at sharing best practice and experience.
Confirmed speakers / participants include:
The event starts at 9.30am and is free to attend. To register a place, please email firstname.lastname@example.orgDownload 278.6 KB